Fig. 6From: Melittin-MIL-2 fusion protein as a candidate for cancer immunotherapyThe melittin-MIL-2 reduced lung metastasis of MDA-MB-231 mammary cancer cells. The number of tumor nodules on the whole surface of the lungs was counted using a microscope. The administered melittin-MIL-2 reduced metastasis to the lung by 48 % (*p < 0.05)Back to article page